Proteomic analysis of uterine flushings from infertile women in the proliferative phase of the menstrual cycle with respect to estrogen level

Middle East Fertility Society Journal

Volumn 11, Issue 3, 2006, Pages 183-190

  Al Rumaih, Hazem M ^a,b   Gillott, David J ^a   Price, Karen M ^a   Grudzinskas, Gedis J ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Electrophoresis; Endometrium; In vitro fertilization; Infertility; Proteomics

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; COMPLEMENT COMPONENT C4; ESTROGEN; FIBRINOGEN; PROTEIN PRECURSOR; TRANSFERRIN;

ADULT; ARTICLE; BETA CHAIN; BLOOD CLOTTING; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; GEL; GYNECOLOGIC CARE; HUMAN; IRON TRANSPORT; MENSTRUAL CYCLE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SILVER STAINING; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; UTERUS CAVITY;

EID: 33947228799     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Byrjalsen I, Mose Larsen P, Fey SJ, Thormann L, Pederson BJ and Christiansen C. Two-dimensional gel analysis of human endometrial proteins: cyclic changes in the expression of specific proteins during the normal menstrual cycle. Human Reproduction 1995; 10(1): 13-18.
2. MacLaughlin DT, Richardson GS, Santoro NF, Hargraves AA and Bauer HH. Analysis of proteins secreted by the human endometrium in-vivo and in-vitro. Adv. Exp. Med. Biol. 1987; 230: 151-6
3. Fay TN, Lindenberg S, Teisner B, Westergaard LG, Westergaard JG and Grudzinskas JG. Identification of specific serum proteins synthesized de novo by monolayer cultures of glandular cells of gestational endometrium. Hum Reprod. 1990; 5(1):14-8.
4. Hamilton JA, Iles RK, Gunn LK, Wilson CM, Lower AM, Chard T, Grudzinskas JG. Concentrations of placental protein 14 in uterine flushings from infertile women: validation of the collection technique and method of expression of results. Hum Reprod. 1998;13(12):3357-62.
5. Gorg A, Postel W, Gunther S and Weser J. Improved horizontal two-dimensional electrophoresis with hybrid isoelectric focusing in immobilized pH gradients in the first dimension and laying-on transfer to the second dimension. Electrophoresis 1985; 6: 599-604.
6. Blum H, Beier H and Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987; 8: 93-9.
7. Finlay TH, Katz J, Rasums A, Seiler S and Levitz M. Estrogen stimulated uptake of alpha 1-protease inhibitor and other plasma proteins by the mouse uterus. Endocrinology 1991; 108(6): 2129-36.
8. Paoli M, Anderson BF, Baker HM, Morgan WT, Smith A and Baker EN. Crystal structure of hemopexin reveals a novel high affinity heme site formed between two β-propeller domains. Nature structural biology 1999; 6(10): 926-931.
9. Smith A and Hunt RC. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. Eur. J. Cell Biol. 1990; 53(2): 234-45.
10. Katz NR, Giffhorn S, Goldfarb V and Muller-Eberhard U. Partial characterization of intra- and extracellular forms of the glycoprotein hemopexin in liver cell culture and cell-free translation. Biochem Biophys Res Commun. 1985; 131(2): 593-9.
11. Smith A Links between cell surface events involving redox-active copper and gene regulation in the hemopexin heme transport system. Antioxid Redox Signal 2000; 2(2): 157-75.
12. Byrjalsen I, Mose Larsen P, Fey SJ, Nilas L, Larsen MR and Christiansen C. Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma. Molecular Human Reproduction 1999; 5(8): 748-756.
13. Persson I, Yuen J, Bergkvist L and Scairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long term follow-up of a Swedish cohort. Int. J. Cancer 1996; 67(3): 327-32.
14. Aune B, Hoie KE, Oian P, Holst N, Osterud B. Does ovarian stimulation for in-vitro fertilization produce a hypercoagulable state? Hum. Reprod. 1991; 6(7): 925-7.
15. Andersson O, Blomback M, Bremme K and Wramsby H. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation. Throb Haemost. 1997; 77(5): 901-4.
16. Feuring M, Christ M, Roell A, Shueller P, Losel R, Dempfle CE, Shultz A and Wehling M. Alterations in platelet function during the ovarian cycle. Blood Coagul Fibrinolysis. 2002; 13(5): 443-7.
17. Asahina T, Kobayashi T, Okada Y, Itoh M, Yamashita M, Inamoto Y and Terao T Studies on the role of adhesive proteins in maintaining pregnancy. Horm. Res. 1998; 50suppl 2: 37-45.
18. Kalsheker N, Morley S and Morgan K. Gene regulation of the serine proteinase inhibitors α1-antitrypsin and α1-antichymotrypsin. Biochemical Society Transactions 2002; 30(2): 93-98.
19. Marshall RJ and Braye SG. Immunohistochemical demonstration of alpha-1-antirypsin and alpha-1-antichymotrypsin in normal human endometrium. Int. J. Gynecol. Pathol. 1987; 6(1); 49-54.
20. Tauber PF, Cramer GM and Zaneveld LJ. Effect of the intrauterine contraceptive device on protein components of human uterine fluid. Contraception. 1993; Nov. 48(5): 494-512.
21. Schumacher GF, Kim MH, Hosseinian AH and Dupon C. Immunoglobulins, proteinase inhibitors, albumin and lysozyme in human cervical mucus. I. Communication: hormonal profiles and cervical mucus changes - methods and results. Am. J. Obstet. Gynecol. 1977; 129(6): 629-36.
22. Casslen B. Inhibitors of trypsin, chymotrypsin and elastase in human uterine fluid. Acta Obstet Gynecol Scand. 1986;65(2):121-4.
23. Chen Z, Koralov SB and Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 2000;192(9):1339-52.
24. Jin M, Larsson A and Nilsson BO. A functionally active complement system is present in uterine secretion of the mouse prior to implantation. Am. J. Reprod. Immunol. 1991;26(2); 53-7.
25. Yilmazer M, Fenkci V, Fenkci S, Aktepe O, Sonmezer M, Kurtay G. Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women. Hum Reprod. 2003;18(7):1531-5.
26. Sundstrom SA, Komm BS, Ponce-de-Leon H, Yi Z, Teuscher C and Lyttle CR. Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem. 1989;264(28): 16941-7.